Literature DB >> 2642587

Clinical and serologic characteristics of patients with overlap syndrome: is mixed connective tissue disease a distinct clinical entity?

M A Lázaro1, J A Maldonado Cocco, L J Catoggio, S M Babini, O D Messina, O García Morteo.   

Abstract

We discuss the clinical and serologic features of 27 patients with overlap syndrome followed prospectively by our group. The findings are similar to those of other reports, but we have drawn attention to the presence of peritendinous nodules in these patients and mentioned some peculiar neurologic manifestations. Rheumatoid arthritis was the most common diagnosis in our patients. The presence of high-titer antibodies against the nuclear ribonucleoprotein fraction of extractable nuclear antigen (nRNP) did not allow the identification of a particular subgroup. However, patients with this antibody tended to fulfill more criteria of more diseases than those without it. The findings lead us to conclude that antibodies to nRNP do not identify a particular subgroup within the overlap syndromes and that mixed connective tissue disease does not appear to be a distinct entity.

Entities:  

Mesh:

Year:  1989        PMID: 2642587     DOI: 10.1097/00005792-198901000-00004

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  7 in total

1.  Imbalance of CD4+ lymphocyte subsets in patients with mixed connective tissue disease.

Authors:  H Becker; A Langrock; K Federlin
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

Review 2.  'Overlap' syndromes.

Authors:  R Cervera; M A Khamashta; G R Hughes
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

3.  Mixed connective tissue disease. A clinico-serological study of 17 cases.

Authors:  I García-de la Torre; M Salazar-Páramo; G Salmón-de la Torre
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

4.  Neurological features in overlap syndrome.

Authors:  A Nitsche; R C Leiguarda; J A Maldonado Cocco; M A Lázaro; O Garcia Morteo
Journal:  Clin Rheumatol       Date:  1991-03       Impact factor: 2.980

5.  Distribution and antigen specificity of anti-U1RNP antibodies in patients with systemic sclerosis.

Authors:  H Ihn; K Yamane; N Yazawa; M Kubo; M Fujimoto; S Sato; K Kikuchi; K Tamaki
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

6.  Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis.

Authors:  H Ihn; S Sato; M Fujimoto; A Igarashi; N Yazawa; M Kubo; K Kikuchi; K Takehara; K Tamaki
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

7.  Antigen specificity of antihistone antibodies in connective tissue disease patients with anti-U1RNP antibodies.

Authors:  Takamasa Wayaku; Minoru Hasegawa; Kenzo Kaji; Miki Kondo; Yuki Saito; Hidemitsu Orito; Mayuka Horikawa; Takashi Matsushita; Kazuhiro Komura; Ikuko Hayakawa; Yasuhito Hamaguchi; Fumihide Ogawa; Manabu Fujimoto; Kazuhiko Takehara; Shinichi Sato
Journal:  Rheumatol Int       Date:  2007-07-13       Impact factor: 2.631

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.